Clinical trials
Observational Hemophilia B trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 4 |
| 2020 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Terminated | 6 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 5 |
| American Thrombosis and Hemostasis Network | 4 |
| Baxalta now part of Shire | 3 |
| CSL Behring | 2 |
| St. Jude Children's Research Hospital | 2 |
| Weill Medical College of Cornell University | 2 |
| ApcinteX Ltd | 1 |
| Bioverativ Therapeutics Inc. | 1 |
| Bloodworks | 1 |
| Children's Mercy Hospital Kansas City | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia B | 35 |
| Hemophilia A | 22 |
| Anemia, Sickle Cell | 3 |
| Hematologic Diseases | 3 |
| Thrombosis | 3 |
| Hemarthrosis | 2 |
| Hemostatic Disorders | 2 |
| Mucopolysaccharidosis I | 2 |
| Mucopolysaccharidosis II | 2 |
| von Willebrand Diseases | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.